Ascendis Pharma Commences Public Offering Of $300M Of ADSs
Ascendis Pharma Commences Public Offering Of $300M Of ADSs
Ascendis Pharma開始公開發行30000萬美元的ADSs
All of the ADSs are being offered by Ascendis. In addition, Ascendis expects to grant the underwriters a 30-day option to purchase up to an additional $45 million of ADSs at the public offering price, less the underwriting commissions.
所有板塊的ADSs均由Ascendis提供。此外，Ascendis希望向承銷商授予一個爲期30天的選擇權，以公開發行價格購買多達額外4500萬美元的ADSs，扣除承銷佣金。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。